Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU
Stronger Sell Today RDY ranks #4290 as SELL CANDIDATE #4290 Weaker Sell

RDY stock forecast Dr Reddy's Laboratories Ltd

RDY stock forecast

Monday June 24, 2019 Change 0.08% Price $36.08
Chart period: 2019-03-25 - 2019-06-24




Social Sentiment for RDY

Today's data is from 4 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
Weighted Sentiment 0.00

Will RDY stock price go up or down on Wed, 26 Jun 2019?


Dr Reddy's Laboratories Ltd Forecast and Stock Analysis

Technical RDY stock analysis for Monday June 24, 2019.

Sell candidate since 2019-06-04 Loss -8.26%

Dr Reddy's Laboratories Ltd gained 0.08% in the last trading day ( Monday, 24th Jun 2019 ), rising from $36.05 to $36.08 During day the stock fluctuated 1.87% from a day low at $35.82 to a day high of $36.49. The price has fallen in 6 of the last 10 days and is down by -4.8% for this period. Volume fell in the last day by -290 979 shares, and in total, 198 737 shares bought and sold for approximately $7.17 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the RDY stock price was $39.73 and low was $35.82.
  • 90 day high was $42.82 and low was $35.82.
  • 52 week high for the Dr Reddy's Laboratories Ltd - $42.82 and low - $29.00.


Dr Reddy's Laboratories Ltd lies in the lower of a wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $35.40 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -9.45% during the next 3 months and, with 90% probability hold a price between $32.06 and $36.66 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Friday June 21, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Dr Reddy's Laboratories Ltd holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $36.61 and $38.57. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 22 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Dr Reddy's Laboratories Ltd finds support from accumulated volume at $36.05.

Support: $36.05 Price: $36.08 Resistance: $37.53


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.67 (1.87%) between high and low. For the last week, the stock has had a daily average volatility of 1.76%.

Dr Reddy's Laboratories Ltd is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

1.76 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Dr Reddy's Laboratories Ltd holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Sell Candidate Upgraded
Stronger Sell Today RDY ranks #4290 as SELL CANDIDATE #4290 Weaker Sell

Will RDY stock price go up or down on Wed, 26 Jun 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank